Packer M - Search Results

1

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.

Lee WH, Packer M. Lee WH, et al. Among authors: packer m. Circulation. 1986 Feb;73(2):257-67. doi: 10.1161/01.cir.73.2.257. Circulation. 1986. PMID: 3002660

2

Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.

Packer M, Lee WH, Kessler PD, Medina N, Yushak M, Gottlieb SS. Packer M, et al. J Am Coll Cardiol. 1987 Oct;10(4):837-44. doi: 10.1016/s0735-1097(87)80278-4. J Am Coll Cardiol. 1987. PMID: 2821091 Free article.

3

Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure.

Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Packer M, et al. Circulation. 1987 May;75(5 Pt 2):IV80-92. Circulation. 1987. PMID: 2882867 Review.

4

Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.

Packer M, Medina N, Yushak M, Lee WH. Packer M, et al. Br Heart J. 1985 Sep;54(3):298-304. doi: 10.1136/hrt.54.3.298. Br Heart J. 1985. PMID: 2994697 Free PMC article.

5

Comparison of captopril and enalapril in patients with severe chronic heart failure.

Packer M, Lee WH, Yushak M, Medina N. Packer M, et al. N Engl J Med. 1986 Oct 2;315(14):847-53. doi: 10.1056/NEJM198610023151402. N Engl J Med. 1986. PMID: 3018566 Clinical Trial.

6

Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.

Packer M, Lee WH, Kessler PD. Packer M, et al. Circulation. 1986 Oct;74(4):766-74. doi: 10.1161/01.cir.74.4.766. Circulation. 1986. PMID: 3019586

7

Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.

Packer M, Lee WH, Medina N, Yushak M, Kessler PD, Gottlieb SS. Packer M, et al. Am J Med. 1987 Jun;82(6):1119-26. doi: 10.1016/0002-9343(87)90213-0. Am J Med. 1987. PMID: 3037896

8

Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

Packer M, Kessler PD, Lee WH. Packer M, et al. Circulation. 1987 Jun;75(6 Pt 2):V56-64. Circulation. 1987. PMID: 3552317 Review.

9

Can we expect vasodilator therapy to prolong life in patients with congestive heart failure?

Packer M, Lee WH, Kessler PD, Gottlieb SS. Packer M, et al. J Cardiovasc Pharmacol. 1987;9 Suppl 2:S73-5. doi: 10.1097/00005344-198700002-00015. J Cardiovasc Pharmacol. 1987. PMID: 2441205

10

Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure.

Packer M, Lee WH, Medina N, Yushak M. Packer M, et al. Ann Intern Med. 1986 Feb;104(2):147-54. doi: 10.7326/0003-4819-104-2-147. Ann Intern Med. 1986. PMID: 2936291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,092 results

Search Page

Filters